June 2018

Features

IOP Around the Clock: How Close Are We?

Intraocular pressure fluctuates every day and night. When will 24-hour monitoring inform treatment decisions?

Can Sustained Release Deliver the Goods?

The hope is that sustained-release glaucoma drugs will overcome compliance challenges.

Choosing MIGS (for You and Your Patient)

With more options rapidly appearing, picking the right procedure can be challenging. Here’s help.

Departments

Review News

Study: Differences in Stability Between Tecnis and Acrysof

Technology Update

Three Femtosecond Lasers Have New Indications

Manufacturers unveiled new 510(K) clearances from the Food and Drug Administration at the 2018 ASCRS meeting.

Medicare Q & A

Compliance Update: “Excluded” Employees

Why providers are excluded from Medicare and how to find out if a potential new hire has been excluded.

Retinal Insider

Stem Cell Therapy in Retinal Disease

A look at how stem cells are generated, and the most promising approaches to employing them in the eye.

Refractive/Cataract Rundown

Shutting the Door on Epithelial Ingrowth

Surgeons share when to watch and wait, and when to do something about ingrowth under the flap.

Glaucoma Management

Two Unique Glaucoma Drugs Debut

Latanoprostene bunod and netarsudil offer surgeons new options in the battle to effectively lower IOP.

Product News

First AI Diagnostic System Approved

Wills Eye Resident Case Series

June 2018 Wills Eye Resident Case Series

A 22-year-old man with eyelid swelling and sinus congestion is evaluated in the Wills Eye Hospital Emergency Room.

Current Issue